World's Best Scientists 2026 revealed!
Vivek Naranbhai

Vivek Naranbhai

D-Index & Metrics

Immunology

D-Index
44
Citations
10419
World Ranking
4754
National Ranking
209

Vivek Naranbhai publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Vivek Naranbhai sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 129 publications — 9th percentile

9% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Vivek Naranbhai D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Vivek Naranbhai sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 44 D-Index — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Vivek Naranbhai is affiliated with Monash University in Australia and primarily conducts research in the field of Medicine. Their subfields of study include Infectious Diseases, Oncology, Immunology, Molecular Biology, and Pulmonary and Respiratory Medicine.

The scientist's research focuses on several main topics, including:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Cancer Immunotherapy and Biomarkers
  • Immune Cell Function and Interaction
  • Tuberculosis Research and Epidemiology
  • Immunotherapy and Immune Responses
  • Vaccines and Immunoinformatics Approaches

Vivek Naranbhai has contributed research articles in several high-impact and specialized publication venues such as:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cell
  • Proceedings of the National Academy of Sciences
  • Journal of Investigative Dermatology
  • Journal of Allergy and Clinical Immunology

The scientist has coauthored frequently with the following researchers:

  • A. John Iafrate
  • Alejandro B. Balazs
  • Wilfredo F. García-Beltrán
  • Justin F. Gainor
  • Evan C. Lam

Selected recent publications by Vivek Naranbhai include:

  • "T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals," 2022, published in Cell
  • "Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity," 2021, published in Cell
  • "Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity," 2021, published in bioRxiv (Cold Spring Harbor Laboratory)

Additional notable papers coauthored by close collaborators include:

  • "Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity," 2021, published in Cell
  • "mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant," 2022, published in Cell

Best Publications

  • mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant

    Unknown

  • Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.

    Wilfredo F. Garcia-Beltran;Wilfredo F. Garcia-Beltran;Evan C. Lam;Kerri St. Denis;Adam D. Nitido

  • Innate immune activity conditions the effect of regulatory variants upon monocyte gene expression.

    Benjamin P. Fairfax;Peter Humburg;Seiko Makino;Vivek Naranbhai

  • Genital Inflammation and the Risk of HIV Acquisition in Women

    Lindi Masson;Lindi Masson;Jo Ann S. Passmore;Jo Ann S. Passmore;Lenine J. Liebenberg;Lise Werner

  • T-cell activation is an immune correlate of risk in BCG vaccinated infants

    Helen A. Fletcher;Helen A. Fletcher;Margaret A. Snowden;Bernard Landry;Wasima Rida

  • Erratum: Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity (Cell (2021) 184(9) (2372–2383.e9), (S0092867421002981), (10.1016/j.cell.2021.03.013))

    Wilfredo F. Garcia-Beltran;Wilfredo F. Garcia-Beltran;Evan C. Lam;Kerri St. Denis;Adam D. Nitido

  • T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals

    Unknown

  • Comparative Immunogenicity and Effectiveness of mRNA-1273, BNT162b2, and Ad26.COV2.S COVID-19 Vaccines

    Unknown

  • Genomic modulators of gene expression in human neutrophils

    Vivek Naranbhai;Benjamin P. Fairfax;Seiko Makino;Peter Humburg

  • HLA-A*03 and response to immune checkpoint blockade in cancer: an epidemiological biomarker study.

    Unknown

  • Innate immune activation enhances HIV acquisition in women, diminishing the effectiveness of tenofovir microbicide gel.

    Vivek Naranbhai;Vivek Naranbhai;Salim S. Abdool Karim;Salim S. Abdool Karim;Marcus Altfeld;Marcus Altfeld;Natasha Samsunder

  • Elevated HLA-A expression impairs HIV control through inhibition of NKG2A-expressing cells

    Veron Ramsuran;Vivek Naranbhai;Amir Horowitz;Ying Qi

  • Ratio of Monocytes to Lymphocytes in Peripheral Blood Identifies Adults at Risk of Incident Tuberculosis Among HIV-Infected Adults Initiating Antiretroviral Therapy

    Vivek. Naranbhai;Adrian V. S. Hill;Adrian V. S. Hill;Salim Safurdeen. Abdool Karim;Kogieleum. Naidoo

  • Germline variants associated with toxicity to immune checkpoint blockade

    Unknown

  • A systematic review of definitions of extreme phenotypes of HIV control and progression.

    Deepti Gurdasani;Louise Iles;David G. Dillon;Elizabeth H. Young

  • Clinical and mycological predictors of cryptococcosis-associated immune reconstitution inflammatory syndrome.

    Christina Catherine Chang;Afton A Dorasamy;Bernadett Gosnell;Julian Elliott

  • The association between the ratio of monocytes:lymphocytes at age 3 months and risk of tuberculosis (TB) in the first two years of life

    Vivek Naranbhai;Vivek Naranbhai;Soyeon Kim;Helen Fletcher;Mark F Cotton

  • Polymorphism in a lincRNA Associates with a Doubled Risk of Pneumococcal Bacteremia in Kenyan Children

    Anna Rautanen;Matti Pirinen;Tara C Mills;Kirk A Rockett;Kirk A Rockett

  • IFITM3 and Susceptibility to Respiratory Viral Infections in the Community

    Tara C. Mills;Anna Rautanen;Katherine S. Elliott;Tom Parks

  • CCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcome.

    Smita Kulkarni;Smita Kulkarni;Alexandra Lied;Viraj Kulkarni;Viraj Kulkarni;Marijana Rucevic

  • The Ratio of Monocytes to Lymphocytes in Peripheral Blood Correlates with Increased Susceptibility to Clinical Malaria in Kenyan Children

    George M. Warimwe;Linda M. Murungi;Gathoni Kamuyu;George M. Nyangweso

  • Distinct Transcriptional and Anti-Mycobacterial Profiles of Peripheral Blood Monocytes Dependent on the Ratio of Monocytes: Lymphocytes.

    Vivek Naranbhai;Helen A. Fletcher;Helen A. Fletcher;Rachel Tanner;Matthew K. O'Shea

  • High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea, Massachusetts.

    Vivek Naranbhai;Christina C Chang;Christina C Chang;Christina C Chang;Wilfredo F Garcia Beltran;Tyler E Miller

  • Changes in Natural Killer cell activation and function during primary HIV-1 Infection.

    Vivek. Naranbhai;Vivek. Naranbhai;Marcus. Altfeld;Marcus. Altfeld;Salim Safurdeen. Abdool Karim;Salim Safurdeen. Abdool Karim;Thumbi. Ndung'u;Thumbi. Ndung'u

  • Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study.

    Vivek Naranbhai;Vivek Naranbhai;Claire A Pernat;Alexander Gavralidis;Alexander Gavralidis;Kerri J St Denis

  • Author Correction: CCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcome.

    Smita Kulkarni;Smita Kulkarni;Alexandra Lied;Viraj Kulkarni;Viraj Kulkarni;Marijana Rucevic

Frequent Co-Authors

Quarraisha Abdool Karim
Quarraisha Abdool Karim Centre for the AIDS Programme of Research in South Africa
Salim S. Abdool Karim
Salim S. Abdool Karim Centre for the AIDS Programme of Research in South Africa
Mary Carrington
Mary Carrington Ragon Institute of MGH, MIT and Harvard
Adrian V. S. Hill
Adrian V. S. Hill University of Oxford
Thumbi Ndung'u
Thumbi Ndung'u University of KwaZulu-Natal
Marcus Altfeld
Marcus Altfeld University Medical Center Hamburg-Eppendorf
Helen A. Fletcher
Helen A. Fletcher London School of Hygiene & Tropical Medicine
Bruce D. Walker
Bruce D. Walker Harvard University
Helen McShane
Helen McShane University of Oxford
Julian C. Knight
Julian C. Knight University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their expertise beyond immunology, various online nursing programs provide flexible pathways into healthcare roles closely tied to immunology research and patient care. Students without a nursing background can explore online RN programs for non nurses, which offer an accessible entry point into the nursing profession while building foundational clinical skills.

For registered nurses aiming to advance quickly, nurse practitioner accelerated program options provide accelerated routes to achieve advanced practice licensure. These programs are ideal for those looking to specialize further, including in areas related to immunology.

Specialized paths such as acute care nurse practitioner programs allow practitioners to hone skills in managing complex, immunology-related conditions in acute and critical care settings. This specialization bridges the gap between immunology knowledge and direct patient intervention.

Additionally, for those seeking the most accessible entry points, the easiest accelerated nursing programs to get into provide practical options to fast-track nursing degrees and begin careers related to immunology support roles without lengthy barriers to entry.

Best Scientists Citing Vivek Naranbhai

Trending Scientists